Bausch Health Companies Inc. has announced new shareholder agreements with major investor groups, including the Icahn Group, the Paulson Group, and the Kavanagh Group, as of May 20, 2025. These agreements dictate that if any group engages in a "Specified Action," such as initiating a proxy contest against the company, they must resign from the boards of both Bausch Health and Bausch + Lomb. Furthermore, the Icahn Group has agreed to waive certain rights from previous agreements. As long as no specified actions are taken, the company will support group nominees for board elections and appointments to new board committees, provided no conflicts of interest arise. Full details of these agreements are available in the attached exhibits.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.